199 related articles for article (PubMed ID: 6234377)
1. Catecholamines and serotonin in the rat central nervous system after 6-OHDA, 5-7-DHT and p-CPA.
Reader TA; Gauthier P
J Neural Transm; 1984; 59(3):207-27. PubMed ID: 6234377
[TBL] [Abstract][Full Text] [Related]
2. Effects of adult or neonatal treatment with 6-hydroxydopamine or 5,7-dihydroxytryptamine on locomotor activity, monoamine levels, and response to caffeine.
Erinoff L; Snodgrass SR
Pharmacol Biochem Behav; 1986 Apr; 24(4):1039-45. PubMed ID: 3086901
[TBL] [Abstract][Full Text] [Related]
3. [Effect of the local administration of 5,7-DHT and 6-OHDA into the neocortex on the learning and exploratory behavior of rats in an open field].
Ismaĭlova KhIu; Gasanov GG; Semenova TP; Bobkova NV; Nesterova IV
Zh Vyssh Nerv Deiat Im I P Pavlova; 1989; 39(3):548-55. PubMed ID: 2552698
[TBL] [Abstract][Full Text] [Related]
4. Neonatal intraspinal 6-hydroxydopamine, 5,7-dihydroxytryptamine or their combination: effects on nociception and morphine analgesia.
Pappas B; Ings R; Roberts D
Eur J Pharmacol; 1982 Dec; 86(2):157-66. PubMed ID: 6819155
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of the non-specific effects of catecholamine and serotonin neurotoxins by injection into the medial forebrain bundle of the rat.
Lorden JF; Oltmans GA; Dawson R; Callahan M
Pharmacol Biochem Behav; 1979 Jan; 10(1):79-86. PubMed ID: 312504
[TBL] [Abstract][Full Text] [Related]
6. Adrenomedullary secretory response to midbrain stimulation in rat: effects of depletion of brain catecholamines or serotonin.
Gauthier P; Reader TA
Can J Physiol Pharmacol; 1982 Dec; 60(12):1464-74. PubMed ID: 6219734
[TBL] [Abstract][Full Text] [Related]
7. Catecholamines and serotonin in rat frontal cortex after PCPA and 6-OHDA: absolute amounts and ratios.
Reader TA
Brain Res Bull; 1982 May; 8(5):527-34. PubMed ID: 6214300
[TBL] [Abstract][Full Text] [Related]
8. [Effect of the intracisternal administration of the neurotoxins 6-hydroxydopamine and 5,7-dihydroxytryptamine on the formation of the passive avoidance reaction and the biogenic amine level in the brain of rats].
Shabanov PD; Bul'on VV; Lénárd L
Fiziol Zh SSSR Im I M Sechenova; 1988 Jul; 74(7):920-3. PubMed ID: 3141223
[TBL] [Abstract][Full Text] [Related]
9. Tonic convulsive thresholds and responses during the postnatal development of rats administered 6-hydroxydopamine or 5,7-dihydroxytryptamine within three days following birth.
Waller SB; Buterbaugh GG
Pharmacol Biochem Behav; 1983 Dec; 19(6):973-8. PubMed ID: 6419239
[TBL] [Abstract][Full Text] [Related]
10. The effects of 5,7-dihydroxytryptamine and p-chlorophenylalanine on thyrotrophin-releasing hormone in regions of the brain and spinal cord of the rat.
Lighton C; Marsden CA; Bennett GW
Neuropharmacology; 1984 Jan; 23(1):55-60. PubMed ID: 6232468
[TBL] [Abstract][Full Text] [Related]
11. Serotonin-lesion myoclonic syndromes. I. Neurochemical profile and S-1 receptor binding.
Pranzatelli MR; Rubin G; Snodgrass SR
Brain Res; 1986 Jan; 364(1):57-66. PubMed ID: 3484992
[TBL] [Abstract][Full Text] [Related]
12. Cotransmitters: differential effects of serotonin (5-HT)-depleting drugs on levels of 5-HT and TRH and their receptors in rat brain and spinal cord.
Sharif NA; Towle AC; Burt DR; Mueller RA; Breese GR
Brain Res; 1989 Feb; 480(1-2):365-71. PubMed ID: 2540880
[TBL] [Abstract][Full Text] [Related]
13. 6-Hydroxydopamine and 5,7-dihydroxytryptamine selectively reduce dopamine and 5-hydroxytryptamine metabolites in cerebroventricular perfusates of rats.
Nielsen JA; Moore KE
Pharmacol Biochem Behav; 1983 Nov; 19(5):905-7. PubMed ID: 6417682
[TBL] [Abstract][Full Text] [Related]
14. Changes in sensitivity to intrathecal norepinephrine and serotonin after 6-hydroxydopamine (6-OHDA), 5,6-dihydroxytryptamine (5,6-DHT) or repeated monoamine administration.
Howe JR; Yaksh TL
J Pharmacol Exp Ther; 1982 Feb; 220(2):311-21. PubMed ID: 6120226
[TBL] [Abstract][Full Text] [Related]
15. Influence of local injection of 5,7-DHT and 6-OH-DA into the neocortex on learning and exploratory behavior of rats in the open field.
Ismailova KhY; Gasanov GG; Semenova TP; Bobkova NV; Nesterova IV; Gromova EA
Neurosci Behav Physiol; 1990; 20(6):493-9. PubMed ID: 2128948
[TBL] [Abstract][Full Text] [Related]
16. Effect of modification of brain serotonin (5-HT), norepinephrine (NE) and dopamine (DA) on ethanol tolerance.
Lê AD; Khanna JM; Kalant H; LeBlanc AE
Psychopharmacology (Berl); 1981; 75(3):231-5. PubMed ID: 6798612
[TBL] [Abstract][Full Text] [Related]
17. Involvement of spinal monoaminergic pathways in antinociception produced by substance P and neurotensin in rodents.
Naranjo JR; Arnedo A; Molinero MT; Del Rio J
Neuropharmacology; 1989 Mar; 28(3):291-8. PubMed ID: 2471111
[TBL] [Abstract][Full Text] [Related]
18. Long-lasting depletion of spinal cord 5-hydroxytryptamine or catecholamines after intraspinal injection of 5,7-dihydroxytryptamine or 6-hydroxydopamine to newborn rats.
Carruba MO; Keller HH; Da Prada M
Neurosci Lett; 1983 Feb; 35(2):173-8. PubMed ID: 6190112
[No Abstract] [Full Text] [Related]
19. Effects of neonatal treatment with 5,7-dihydroxytryptamine or 6-hydroxydopamine on the ontogenetic development of the audiogenic immobility reaction in the rat.
Hard E; Ahlenius S; Engel J
Psychopharmacology (Berl); 1983; 80(3):269-74. PubMed ID: 6412273
[TBL] [Abstract][Full Text] [Related]
20. Effects of reserpine, alpha-methyl-p-tyrosine, p-chlorophenylalanine and 5,7-dihydroxytryptamine on the hippocampal kindling effect in rats.
Araki H; Aihara H; Watanabe S; Yamamoto T; Ueki S
Jpn J Pharmacol; 1983 Dec; 33(6):1177-82. PubMed ID: 6230476
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
